Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial

Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

NCT01242787 ·Status: UNKNOWN ·Phase: PHASE2

A Study of LW231 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection

NCT06311734 ·Status: COMPLETED ·Phase: PHASE1

Prospective Observational Cohort Study for the Durability of Anti-viral Therapy in Patients With Chronic Hepatitis B

NCT01533051 ·Status: UNKNOWN

Switching From TDF to TAF vs. Maintaining TDF in Chronic Hepatitis B With Resistance to Adefovir or Entecavir.

NCT03241641 ·Status: COMPLETED ·Phase: PHASE4

Evaluate the Efficacy and Safety to Tenofovir Disoproxil in Chronic Hepatitis B Patients

NCT03485534 ·Status: COMPLETED ·Phase: PHASE4

Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B

NCT00531167 ·Status: COMPLETED ·Phase: PHASE4

A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection

NCT00393484 ·Status: COMPLETED ·Phase: PHASE4

Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis B

NCT01270165 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients

NCT00798460 ·Status: TERMINATED ·Phase: PHASE4

Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B

NCT00324961 ·Status: COMPLETED ·Phase: PHASE4

A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in Chronic Hepatitis B (CHB) Subjects

NCT03020745 ·Status: COMPLETED ·Phase: PHASE2

Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria

NCT04264312 ·Status: COMPLETED

Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

NCT01026610 ·Status: COMPLETED ·Phase: PHASE2

Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia)

NCT00338780 ·Status: COMPLETED ·Phase: PHASE4

Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance

NCT06779864 ·Status: RECRUITING

Long-term Study on Anti-HBV Effect of Tenofovir and Resistance Surveillance in Asian-American Adult Patients

NCT01267162 ·Status: COMPLETED

Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV Infection

NCT00810524 ·Status: UNKNOWN ·Phase: PHASE4

Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNA

NCT00637663 ·Status: COMPLETED ·Phase: PHASE4

Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA

NCT00625560 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Dual-plasmid Hepatitis B Virus DNA Vaccine in Chronic Hepatitis B Patients

NCT01487876 ·Status: UNKNOWN ·Phase: PHASE2

Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines

NCT03753074 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function

NCT00641082 ·Status: COMPLETED ·Phase: PHASE4

A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV

NCT02751996 ·Status: COMPLETED ·Phase: PHASE2

A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis B

NCT04225715 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Efficacy and Safety of Burfiralimab(hzVSF-v13) and OAD (Oral Antiviral Drug)

NCT05808335 ·Status: UNKNOWN ·Phase: PHASE2